SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-044271
Filing Date
2021-08-13
Accepted
2021-08-13 15:09:38
Documents
75
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q lhdx-10q_20210630.htm   iXBRL 10-Q 3185287
2 EX-10.1 lhdx-ex101_99.htm EX-10.1 122372
3 EX-31.1 lhdx-ex311_7.htm EX-31.1 20845
4 EX-31.2 lhdx-ex312_9.htm EX-31.2 20814
5 EX-32.1 lhdx-ex321_6.htm EX-32.1 9730
6 EX-32.2 lhdx-ex322_8.htm EX-32.2 8365
  Complete submission text file 0001564590-21-044271.txt   11199641

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA lhdx-20210630.xsd EX-101.SCH 63800
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE lhdx-20210630_cal.xml EX-101.CAL 48673
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE lhdx-20210630_def.xml EX-101.DEF 225476
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE lhdx-20210630_lab.xml EX-101.LAB 501098
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lhdx-20210630_pre.xml EX-101.PRE 409677
12 EXTRACTED XBRL INSTANCE DOCUMENT lhdx-10q_20210630_htm.xml XML 2129299
Mailing Address 1412 62ND STREET EMERYVILLE CA 94608
Business Address 1412 62ND STREET EMERYVILLE CA 94608 (814) 574-1546
Lucira Health, Inc. (Filer) CIK: 0001652724 (see all company filings)

IRS No.: 272491037 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39976 | Film No.: 211171709
SIC: 2835 In Vitro & In Vivo Diagnostic Substances